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ABSTRACT 
Western studies in the recent past have suggested that reducing the duration of 
untreated psychosis (DUP) is associated with better control of symptoms of 
schizophrenia. The present investigation attempts to assess the influence of duration 
of untreated psychosis and other predictors on the outcome of schizophrenia, six 
weeks after the treatment. Data of 45 DSM-IV schizophrenia patients (Mean age 
31 ± 9.2; 27 males) who were treated for the first time formed the sample. Based 
on the clinical notes in files two psychiatrists independently rated the outcome at 
6-8 weeks of neuroleptic treatment. The inter rater agreement was good. Improved 
and unimproved groups did not differ on any variables except the duration of 
untreated psychosis. Duration of untreated psychosis was longer in the unimproved 
group. In a logistic regression model, only duration of untreated psychosis emerged 
as a significant predictor (OR= 0.9854. with 95% Cl= 0.9717 - 0.9993; p=0.039). 
DUP affects acute outcome in schizophrenia. 
Key words: Acute outcome, DUP. Logistic Regression, Predictors, Psychosis, 
Schizophrenia. 
INTRODUCTION 
Studies, all from the West, in the recent 
past have suggested that reduction of 
duration of untreated psychosis (DUP) is 
associated with better control of symptoms/ 
outcome of Schizophrenia. Many authors 
have argued that reducing the time between 
onset of psychosis and institution of 
treatment mav result in substantially 
improved outcomes for schizophrenia and 
related disorder (McGlashan & Johannessen, 
19%; Met Sorry et al. 19%). It has also been 
suggested that psychosis itself may have 
toxic effects on brain (Grace, 1991; Wyatt, 
1991). 
Most of the retrospective studies found 
the outcome to be correlated with shorter 
duration of psychosis before first treatment. 
Fcnton & McGlashan (1987) described a 
subgroup of 23 patients who, after a period 
of inpatient treatment sustained good 
outcome without maintenance medication 
for an average of 15 years. Compared to 
the rest of the sample (n=140), these 
patients had shorter period of untreated 
psychosis. Lo & Lo (1977) in a ten year 
retrospective folJow-up of 133 patients in 
China found die outcome to be correlated 
with shorter duration of untreated psychosis. 
In a prospective study, Loebel et al 
(1992) found that DUP predicted time to 
remission and also the level of remission 
in a group of predominandy drug naive 
schizophrenic and schizoaffective patients. 
The influence of DUP on time to remission 
was independent of gender and diagnosis. 
Similar results were reported by Robinson 
et al (1999). Szymanski et al (1996) in their 
follow-up data on 36 patients with drug 
naive schizophrenia reported that longer 
DUP was associated with less change in 
positive symptoms. This was independent 
of age, gender, or baseline severity of 
symptoms. 
However, some studies have found no 
relationship between DUP and outcome. 
Craig et al (2000) followed up patients with 
psychosis of various diagnostic groups for 
24 months after first admission; patients 
were split into three groups on the basis 
of length of DUP in each diagnostic group. 
In no case, was DUP significantly related 
to die likelihood of attaining a remission. 
Ho et al (20001) in their six-month follow 
up report of 74 drug naive first episode 
schizophrenics found no significant 
relationship between DUP and post hoc 
estimates of time to remission or level of 
symptoms. After reviewing the indirect and 
direct evidences of relationship between 
DUP and outcome Norman & Malla (2001) 
conclude that there is evidence suggesting 
a relationship between DUP and initial 
response to treatment, although robustness 
of such findings is yet to be established. 
Though there is no definitive evidence as 
to whether reduction of DUP will alter the 
course of schizophrenia for better, this issue 
has considerable public heakh importance. 
While studying the influence of DUP on 
the outcome, one needs to consider other 
predictors of outcome of Schizophrenia 
also. A number of socio-demographic, 
clinical, pre-morbid and biological factors 
have also predicted the outcome. Male 
gender, low socioeconomic status, family 
history of schizophrenia, low IQ, longer 
duration of past psychosis etc., were 
predictors of poor outcome across a number 
of follow-up studies (McGlashan, 1986). 
However, despite the knowledge of such 
factors, the prediction of outcome in 
schizophrenia has remained a challenging 
task and is generally poor. One of the well 
established facts and consistent finding about 
outcome of schizophrenia is rhat patients 
from developing countries including India, 
have better outcomes than those from the 
developed countries (Lieberman, 1996; 
Lipton &. Cancro, 1995). Given the low 
psychiatrist-to-population ratio and 
difficulties in reaching a psychiatrist, it is 
unlikely that patients from developing 
countries have shorter DUP than those 
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from the developed countries. .There is a 
need to study the influence of DUP on 
outcome of schizophrenia in the Indian 
context, hence this study. 
MATERIALS & METHODS 
Forty-five never-treated schizophrenia 
patients, fulfilling DSM-IV criteria (APA, 
1994), who were treated under one unit, 
formed the sample. Apart from demographic 
details their Positive and Negative Syndrome 
Scale (PANSS) scores were available before 
treatment. Mean age of the patients was 31 
(±9.2) years. 60 % of the subjects were 
males and socioeconomic status of half of 
the subjects was medium. All were literate, 
had minimum of seven years schooling and 
hence presumably had normal IQ. Over 
half (53%) of the subjects were unmarried. 
Family history of psychosis assessed clinically 
was present in one- third of the subjects 
(35.6%). The mean duration of psychosis 
was four years and the mean age at onset 
27(±8.1) years. Mean PANSS score of the 
subjects was 87(±18.7). 
The response to treatment was assessed 
TABLE I : Comparison between improved and unimproved groups 
Variables 
Sex 
Male 
Female 
SES 
Low 
Middle 
High 
Marital Status 
Never Married 
Ever Married 
Family History for 
Schizophrenia 
Absent 
Present 
Unimproved 
No. 
6 
5 
6 
5 
4 
7 
6 
5 
% 
54.5 
45.5 
54.5 
45.5 
36.4 
63.6 
54.5 
45.5 
Improved 
No. 
18 
10. 
12 
15 
1 
16. 
12 
19 
9 
% 
63.6 
36.4 
42.9 
536 
3.6 
57.1 
42.9 
67.9 
32.1 
c
2 
.317 
.728 
1.365 
1.365 
.608 
P 
.574 
.695 
.243 
.243 
.435 
on the basis of information available in the 
charts approximately at six weeks after the 
commencement of therapy, by two 
psychiatrists separately. The raters were blind 
to all clinical details except the progress 
notes documented between 6-8 weeks. The 
outcome was assessed on a five-point scale, 
based on the progress notes entered in the 
file. Inter-rater reliability was established 
and Kappa was 0.61 l(p = .001). The above 
outcome variable was converted into 
dichotomous, unimproved (no improvement; 
mild improvement) and improved (moderate 
improvement; remission; recovery), and the 
inter-rater reliability statistic Kappa was 
better (0.692, p = .001). For subsequent 
analyses this was the classifying variable. 
Data was analyzed with Chi-square test, t-
test and Logistic regression and all the 
statistical analyses were carried out in SPSS 
(Version 11.0). The level of significance was 
fixed at 0.05. 
RESULTS 
Demographic variables were compared 
between the two outcome groups -
unimproved & improved (Tables I and II). 
The two groups were comparable on all 
variables except one. Duration of Untreated 
Psychosis (DUP) of two outcome groups 
differed significandy. "Unimproved" group 
had longer duration as compared to the 
"improved" group. 
MULTIVARIATE ANALYSIS 
Binary logistic regression using forward 
stepwise method was applied using the 
dichotomous outcome, "Unimproved" and 
"Improved". The following variables were 
entered — age, sex, SF^S, education, marital 
status, duration of psychosis, age at onset, 
family history and PANSS score. The 
model evolved contains duration of untreated 
psychosis and the odds ratio is 0.9854, with 
95% CI (0.9717 - 0.9993), (p = 0.039). As 
duration of untreated psychosis increases, 
the chance of improvement decreases. The 
overall correct prediction rate is 69 % and 
the R
2 is 44 %, i.e., duration of untreated 
psychosis explains 44 % of the variation in 
the outcome variable. 
DISCUSSION 
This study consisted of 45 drug naive 
(never-treated) schizophrenia patients. Their 
outcomes were assessed by two psychiatrists, 
and the inter rater reliability/ agreement was 
good and significant. Results of this 
investigation are similar to the previous 
findings (Fenton & McGlashan , 1987; 
Loebel et al, 1992; Szymanski et al,1996). 
DUP was found to predict the outcome 
significantly however; none of the socio-
demographic factors seem to be significant 
predictors of the outcome. The observation 
that DUP emerged as a significant variable 
in both univariate and multivariate analyses 
confirms that the result obtained is not an 
artifact as the multivariate analysis takes into 
account the covariation, among different 
variables measured in the study. 
The merits of the present study are that 
all patients were treated as in-patients, the 
same psychiatrist team treated them and the 
same diagnostic criteria were uniformly used. 
Two independent psychiatrists who were 
blind to all variables except the progress 
notes did the assessment of acute outcome. 
This study however, also has limitations in 
that the outcome was not assessed on any 
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TABLE I : Comparison between improved and unimproved groups 
Variables 
Age Clears) 
Education (Years) 
DUP (months) 
Age at onset (years) 
PANSS Score 
Unimp 
Mean 
31.18 
8.55 
81.82 
25.64 
87.64 
roved 
SD 
10.69 
4.50 
65.69 
9.11 
21.85 
Improved 
Mean 
31.61 
9.89 
37.50 
28.29 
87.50 
SD 
8.53 
5.46 
45.41 
7.48 
17.33 
P 
.897 
.473 
.021 
.355 
.984 
structured instrument. Also, only acute 
outcome measure was obtained for the 
study. Assessment of DUP involves 
retrospective recall of time of onset of 
psychosis, which has the usual problem of 
recall bias from patient. In the current 
study all patients were accompanied by a 
relative, who had lived with the patient from 
a time before the onset of psychosis. In this 
study, only the socio-demographic variables 
were included. We suggest that the future 
studies include variables such as premorbid 
adjustment, perinatal complications, 
neurological soft signs and subtypes of 
schizophrenia. 
Earlier studies suggested better outcome 
in schizophrenia in India than in the West. 
The patients in this study had an average 
DUP of four years, which is considerably 
more than that reported in the literature 
from the West 1.3 years and 3.2 years 
(Robinson ct al, 1999; Szymanski et al, 
1996). It is conceivable that the reported 
better outcome for Schizophrenia in India 
is unlikely to be because of shorter DUP. 
It may hence suggest some other inherent 
advantage in our population yet to be 
identified. However, instituting treatment 
earlier gives further advantage and can make 
the outcome in our people even brighter. 
In summary, in our population of 
schizophrenia too, longer duration of 
untreated psychosis predicts poor acute 
outcome. 
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